Zacks Investment Research
17 Mar 2026, 15:35 UTC · 26w ago
Verdict
Headline takes no side. We score DGX +0.60 across three claims — strongly bullish.
+0.60strongly bullish
More positive than 75% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
The global home healthcare market is projected to grow from $416.4 billion in 2024 to $747.7 billion by 2030, representing a 10.2% CAGR.
So whatStrong projected revenue growth for a specific sector generally drives positive valuation and investment appetite for the industry.
More positive than 91% of claims this week
Companies including Quest Diagnostics (DGX), DaVita (DVA), Option Care Health (OPCH), and Addus HomeCare (ADUS) are positioned to benefit from the shift toward digital and AI-powered healthcare.
So whatDirectly identifies specific tickers that are expected to capture market share from the digital healthcare transition.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 77% of claims this week
Persistent consumer price inflation remains a concern for the outlook of the outpatient and home healthcare industry.
So whatInflation acts as a headwind to margins and operational costs, creating downside risk for the sector's growth trajectory.
More negative than 73% of claims this week
Which stocks this story touches
More positive than 75% of ticker scores this week
Identified as a company likely to gain from the growth of digital healthcare and home healthcare markets.
More positive than 75% of ticker scores this week
Identified as a company likely to gain from the growth of digital healthcare and home healthcare markets.
More positive than 75% of ticker scores this week
Identified as a company likely to gain from the growth of digital healthcare and home healthcare markets.
More positive than 75% of ticker scores this week
Identified as a company likely to gain from the growth of digital healthcare and home healthcare markets.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
2h ago
Fox Business
54m ago
More positive than 7% of relationship scores this week
[mutual] Both companies are identified as key players in the Zacks Medical – Outpatient and Home Healthcare industry.
More positive than 7% of relationship scores this week
[mutual] Both companies are identified as key players in the Zacks Medical – Outpatient and Home Healthcare industry.
More positive than 7% of relationship scores this week
[mutual] Both companies are identified as key players in the Zacks Medical – Outpatient and Home Healthcare industry.
More positive than 7% of relationship scores this week
[mutual] Both companies are identified as key players in the Zacks Medical – Outpatient and Home Healthcare industry.
More positive than 7% of relationship scores this week
[mutual] Both companies are identified as key players in the Zacks Medical – Outpatient and Home Healthcare industry.
+24.5%
Price agrees with the score
$247.68 vs $198.94 close before publication (Mar 16) · not market-adjusted
DGX chart →
